{"id":"NCT02558231","sponsor":"Actelion","briefTitle":"The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension","officialTitle":"The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Placebo-controlled, Phase 3b Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-01","primaryCompletion":"2019-08-29","completion":"2020-04-20","firstPosted":"2015-09-23","resultsPosted":"2020-09-11","lastUpdate":"2025-03-30"},"enrollment":247,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Pulmonary Arterial Hypertension"],"interventions":[{"type":"DRUG","name":"Macitentan","otherNames":[]},{"type":"DRUG","name":"Tadalafil","otherNames":[]},{"type":"DRUG","name":"Selexipag","otherNames":[]}],"arms":[{"label":"Triple oral combination treatment","type":"EXPERIMENTAL"},{"label":"Dual oral combination treatment","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this clinical trial is to compare the efficacy and safety of an initial triple oral treatment regimen (macitentan, tadalafil, selexipag) versus an initial dual oral treatment regimen (macitentan, tadalafil, placebo) in newly diagnosed, treatment-na√Øve patients with pulmonary arterial hypertension.","primaryOutcome":{"measure":"Change From Baseline to Week 26 in Pulmonary Vascular Resistance (PVR)","timeFrame":"Baseline, Week 26","effectByArm":[{"arm":"Triple Oral Therapy (Macitentan, Tadalafil, and Selexipag)","deltaMin":0.46,"sd":null},{"arm":"Double Oral Therapy (Macitentan, Tadalafil, and Placebo)","deltaMin":0.48,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.4239"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":58,"countries":["United States","Australia","Austria","Belgium","Canada","Denmark","France","Germany","Ireland","Italy","Netherlands","Spain","Sweden","Switzerland","United Kingdom"]},"refs":{"pmids":["34593120"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":58,"n":119},"commonTop":["Headache","Diarrhoea","Oedema Peripheral","Nausea","Pain in Extremity"]}}